secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001104659-22-106786
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome terminates Deloitte as auditor, appoints Ernst & Young effective Oct 4, 2022
--------------------------------------------------------------------------------

- Audit committee terminated Deloitte on Sept 30, 2022; appointed EY effective Oct 4, 2022.
- Deloitte's audits for FY 2021 and 2020 contained no adverse opinion or qualification.
- No disagreements on accounting principles or reportable events during FY 2021-2022 interim periods.
- No prior consultations with EY regarding accounting principles or audit opinions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465922106786/0001104659-22-106786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465922106786/tm2226767d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-106786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer